Chemomab Therapeutics (CMMB) Institutional Ownership $1.63 -0.05 (-2.69%) (As of 02:14 PM ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Chemomab Therapeutics (NASDAQ:CMMB)CurrentInstitutional OwnershipPercentage46.05%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$1.91MNumber ofInstitutional Sellers(last 12 months)0 Get CMMB Insider Trade Alerts Want to know when executives and insiders are buying or selling Chemomab Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CMMB Institutional Buying and Selling by Quarter Ad Porter & CompanyI was wrong. Dead wrong. Deep inside Silicon Valley the alarm bells are ringing… Jeff Bezos just sold $3 billion in Amazon stock. Warren Buffet just sold another 100 million Apple shares. Yet while the insiders are dumping shares, millions of unsuspecting investors are dumping more and more money in… blind to the carnage that’s just around the corner.Click here to watch. Chemomab Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/15/2024 Sphera Funds Management LTD.1,214,575$1.91M0.3%N/A8.458% 2/1/2023 Kestra Private Wealth Services LLC31,241$100K0.0%N/A0.271% 2/14/2022 GSA Capital Partners LLP11,277$78K0.0%N/A0.099% 1/28/2022 ARK Investment Management LLC267,292$1.84M0.0%+48.1%2.344% 11/17/2021 Yahav Achim Ve Achayot Provident Funds Management Co Ltd.3,097$34K0.0%N/A0.027% 11/5/2021 Advisor Group Holdings Inc.54,821$608K0.0%N/A0.481% 11/3/2021 Meitav Dash Investments Ltd.37,567$416K0.0%-7.6%0.330% 9/17/2021Virtu Financial LLC13,180$251K0.0%N/A0.116% 8/25/2021 Marshall Wace LLP63,554$1.21M0.0%N/A0.558% 8/25/2021Marshall Wace North America L.P.44,035$837K0.0%N/A0.386% 8/18/2021 Ikarian Capital LLC290,534$5.53M0.4%N/A2.640% 8/18/2021 Meitav Dash Investments Ltd.40,664$773K0.0%+389.3%0.370% 8/17/2021 Boothbay Fund Management LLC54,729$1.04M0.0%-11.4%0.512% 8/16/2021 Marshall Wace LLP63,554$1.21M0.0%N/A0.594% 8/5/2021 Meitav Dash Investments Ltd.40,664$773K0.0%+389.3%0.380% 5/18/2021 Orbimed Advisors LLC2,578,174$74.02M0.7%N/A110.320% 5/13/2021 Renaissance Technologies LLC7,023$202K0.0%N/A0.301% 5/6/2021 Meitav Dash Investments Ltd.8,311$239K0.0%N/A0.356% (Data available from 1/1/2016 forward) CMMB Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CMMB shares? During the previous two years, the following institutional investors and hedge funds held shares of Chemomab Therapeutics shares: Sphera Funds Management LTD. ($1.91M), Kestra Private Wealth Services LLC ($100K).Learn more on CMMB's institutional investors. What percentage of Chemomab Therapeutics stock is owned by institutional investors? 46.05% of Chemomab Therapeutics stock is owned by institutional investors. Learn more on CMMB's institutional investor holdings. Which institutional investors have been buying Chemomab Therapeutics stock? The following institutional investors have purchased Chemomab Therapeutics stock in the last 24 months: Sphera Funds Management LTD. ($1.21M), and Kestra Private Wealth Services LLC ($31.24K). How much institutional buying is happening at Chemomab Therapeutics? Institutional investors have bought a total of 1,245,816 shares in the last 24 months. This purchase volume represents approximately $2.01M in transactions. Related Companies BCAB Institutional Ownership ANIX Institutional Ownership IMUX Institutional Ownership GNLX Institutional Ownership XFOR Institutional Ownership MIST Institutional Ownership RLMD Institutional Ownership TLSA Institutional Ownership ANVS Institutional Ownership PLX Institutional Ownership This page (NASDAQ:CMMB) was last updated on 11/18/2024 by MarketBeat.com Staff From Our PartnersTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will ...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredBuffett’s Selling Out: Is Your 401(k) About to Get Wiped Out?Let me share something important with you. Just a few weeks ago, Warren Buffett unloaded $932 million worth of...Golden Crest | SponsoredFREE investing Class TOMORROW + 2 FREE BonusesOver the last 37 years on Wall Street, I've developed a unique investing strategy that allows me to find stock...Unstoppable Prosperity | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredA huge crack is forming in the US economyFormer Trump Advisor Warning: “An Economic Rupture Is Coming” The legendary financier Brad Thomas served on...Wide Moat Research | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredShocking footage from Bill Gates’ $100,000,000,000 AI BetIf you missed out on Nvidia, watch this video I just made.Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Chemomab Therapeutics Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Chemomab Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CMMB Stock Alerts